Abstract P132 – Table 1. Sociodemographic and clinical characteristics of study participants (n = 833).
Characteristic		PLHIV with LTBI (n = 70), n (%)	PLHIV without LTBI (n = 320), n (%)	Crude OR (95% CI)	p‐value	HIV‐uninfected individuals with LTBI (n = 49), n (%)	HIV‐uninfected individuals without LTBI (n = 394), n (%)	Crude OR (95% CI)	p‐value
Gender	Male	50 (71.43)	222 (69.38)	1.10 (0.62 to 1.95)	0.735	35 (71.43)	255 (64.72)	1.36 (0.71 to 2.62)	0.353
	Female	20 (28.57)	98 (30.63)			14 (28.57)	139 (35.28)
Age	≤40 years	37 (52.86)	153 (47.81)	1.22 (0.73 to 2.05)	0.445	18 (36.73)	164 (41.62)	0.81 (0.44 to 1.51)	0.512
	>40 years	33 (47.14)	167 (52.19)			31 (63.27)	230 (58.38)
Educational status	Not university	66 (94.29)	243 (75.94)	5.23 (1.85 to 14.81)	0.002	40 (81.63)	258 (65.48)	2.34 (1.10 to 4.97)	0.027
	University	4 (5.71)	77 (24.06)			9 (18.37)	136 (34.52)
Unemployment	Yes	41 (58.57)	108 (33.75)	2.78 (1.64 to 4.71)	<0.001	7 (14.29)	54 (13.71)	1.05 (0.45 to 2.46)	0.912
	No	29 (41.43)	212 (66.25)			42 (85.71)	340 (86.29)
History of contact with TB patient	Yes	11 (15.71)	44 (13.75)	1.17 (0.57 to 2.40)	0.669	8 (16.33)	27 (6.85)	2.65 (1.13 to 6.22)	0.025
	No, unknown	59 (84.29)	276 (86.25)			41 (83.67)	367 (93.15)
Imprisonment in history	Yes	46 (65.71)	96 (30)	4.47 (2.58 to 7.74)	<0.001	12 (24.49)	31 (7.87)	3.80 (1.80 to 8.02)	<0.001
	No	24 (34.29)	224 (70)			37 (75.51)	363 (92.13)
Hepatitis, yes vs no	Anti‐HCV positive (n = 534)	44 (75.86)	85 (34.84)	5.88 (3.05 to 11.34)	<0.001	20 (64.52)	88 (43.78)	2.33 (1.06 to 5.13)	0.035
	HBsAg positive (n = 487)	3 (5.17)	9 (3.72)	1.41 (0.37 to 5.39)	0.614	2 (10.53)	27 (16.07)	0.61 (0.13 to 2.81)	0.530
Smoking	Yes	58 (82.86)	186 (58.13)	3.48 (1.80 to 6.74)	<0.001	23 (46.94)	126 (31.98)	1.88 (1.03 to 3.43)	0.039
	No	12 (17.14)	134 (41.88)			26 (53.06)	268 (68.02)
Intravenous drug use, ever vs never	Ever	50 (71.43)	104 (32.5)	5.19 (2.94 to 9.17)	<0.001	10 (20.41)	28 (7.11)	3.35 (1.52 to 7.41)	0.003
	Never	20 (28.57)	216 (67.5)			39 (79.59)	366 (92.89)
Alcohol abuse	Yes	6 (8.57)	25 (7.81)	1.11 (0.44 to 2.81)	0.832	3 (6.12)	15 (3.81)	1.65 (0.46 to 5.91)	0.443
	No	64 (91.43)	295 (92.19)			46 (93.88)	379 (96.19)
CD4 count at time of HIV diagnosis, ≤350 vs >350 (cells/L) (n = 364)	≤350	26 (41.27)	182 (60.26)
	>350	37 (58.73)	120 (39.74)	2.16 (1.24 to 3.75)	0.006
CD4 count at time of IGRA test, ≤350 vs >350 (cells/L) (n = 383)	≤350	18 (25.71)	115 (36.62)
	>350	52 (74.29)	199 (63.38)	1.67 (0.93 to 2.99)	0.085
HIV RNA at time of HIV diagnosis, copies/mL (n = 336)	<200	8 (13.56)	24 (8.63)
	≥200	51 (86.44)	254 (91.37)	0.60 (0.26 to 1.42)	0.245
HIV RNA at time of IGRA test, copies/mL (n = 378)	<200	41 (58.57)	188 (60.84)
	≥200	29 (41.43)	121 (39.16)	110 (0.65 to 1.86)	0.726